The interruption of romosozumab treatment during COVID lockdown among US post-menopausal women enrolled in Medicare
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The interruption of romosozumab treatment during COVID lockdown among US post-menopausal women enrolled in Medicare
Authors
Keywords
-
Journal
BONE
Volume -, Issue -, Pages 116954
Publisher
Elsevier BV
Online
2023-11-06
DOI
10.1016/j.bone.2023.116954
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Managing Medications and Medication Adherence Among US Adults During the Early Phase of the COVID-19 Pandemic
- (2023) Rebecca J Bartlett Ellis et al. Patient Preference and Adherence
- The association of social vulnerability with colorectal enhanced recovery program failure
- (2023) Burkely P. Smith et al. Surgery Open Science
- State-Level Social Vulnerability Index and Healthcare Access: The Behavioral Risk Factor Surveillance System Survey
- (2022) Mahmoud Al Rifai et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- COVID-19 lockdown negatively impacted on adherence to denosumab therapy: incidence of non-traumatic fractures and role of telemedicine
- (2022) S. De Vincentis et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Dispensing anti-osteoporotic drugs changed during the COVID-19 pandemic
- (2022) Roland Kocijan et al. BONE
- Anti‐osteoporosis medication dispensing by clinical commissioning groups in England – an ecological study of variability in practice and of the effect of the Covid‐19 pandemic
- (2022) Sobia S. Janjua et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Osteoporosis care during the COVID-19 pandemic in the Netherlands: A national survey
- (2021) Joséphine Jeanne Maria Peeters et al. Archives of Osteoporosis
- How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey
- (2021) N. R. Fuggle et al. OSTEOPOROSIS INTERNATIONAL
- Osteoporosis care amidst the prolonged pandemic
- (2021) R. R. Narla et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Adherence to dosing schedule of denosumab therapy for osteoporosis during COVID-19 lockdown: an electronic medical record and pharmacy claims database study from Asia
- (2021) Manju Chandran et al. OSTEOPOROSIS INTERNATIONAL
- Social Vulnerability and Premature Cardiovascular Mortality Among US Counties, 2014 to 2018
- (2021) Safi U. Khan et al. CIRCULATION
- Identifying and managing osteoporosis before and after COVID-19: rise of the remote consultation?
- (2020) Z. Paskins et al. OSTEOPOROSIS INTERNATIONAL
- Persistence and adherence to parenteral osteoporosis therapies: a systematic review
- (2020) G. Koller et al. OSTEOPOROSIS INTERNATIONAL
- Association Between Social Vulnerability and a County’s Risk for Becoming a COVID-19 Hotspot — United States, June 1–July 25, 2020
- (2020) Sharoda Dasgupta et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- PROFILE OF PATIENTS WITH OSTEOPOROTIC FRACTURES AND FACTORS THAT DECREASE PREVENTION
- (2019) Renato Martins Xavier et al. Acta Ortopedica Brasileira
- Addressing Social Determinants to Improve Population Health
- (2019) Michael Silverstein et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A systematic review of factors affecting medication adherence among patients with osteoporosis
- (2018) C. T. Yeam et al. OSTEOPOROSIS INTERNATIONAL
- Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
- (2017) Steven R Cummings et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- (2017) Kenneth G. Saag et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequency of discontinuation of injectable osteoporosis therapies in US patients over 2 years
- (2017) A. Modi et al. OSTEOPOROSIS INTERNATIONAL
- One and two-year persistence with different anti-osteoporosis medications: a retrospective cohort study
- (2017) C. Reyes et al. OSTEOPOROSIS INTERNATIONAL
- Assessment of geriatric predictors of adherence to Zoledronic acid treatment for osteoporosis: a prospective follow-up study
- (2017) Ilker Tasci et al. ACTA CLINICA BELGICA
- A Crisis in the Treatment of Osteoporosis
- (2016) Sundeep Khosla et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- (2016) Felicia Cosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine
- (2014) Nicole C Wright et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Estimation using all available covariate information versus a fixed look-back window for dichotomous covariates
- (2013) Steven M. Brunelli et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Identifying newly approved medications in Medicare claims data: a case study using tocilizumab
- (2013) Jeffrey R. Curtis et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Anti-osteoporotic therapy in Denmark—predictors and demographics of poor refill compliance and poor persistence
- (2012) C. Hansen et al. OSTEOPOROSIS INTERNATIONAL
- Influence of socioeconomic factors on the adherence of alendronate treatment in incident users in Norway
- (2012) Helene M. Devold et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Ability to follow anti-reabsorptive drug treatment in postmenopausal women with reduced bone mass
- (2011) Débora Castro Gomes et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis
- (2009) I. Imaz et al. OSTEOPOROSIS INTERNATIONAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More